Incontinentia pigmenti not all that rare.(Pediatric
Dermatology)(Clinical report)
STANFORD, CALIF. -- A rare genetic disorder that usually is lethal
to male babies and can leave abnormalities of the skin, eyes, and other
body parts in females, may be more common than originally . . .
Acne treatments reviewed, starting with touch.(Pediatric
Dermatology)
STANFORD, CALIF. -- The art and science of treating acne in
adolescents start with touching the patient.
"Many adolescents have a feeling that their acne is very
dirty, and they take it . . .
Oral vitamin D increases cathelicidin in lesional skin.(Atopic
Dermatitis)(Clinical report)
KYOTO, JAPAN -- Supplementation with oral vitamin D boosted
chronically low levels of the antimicrobial peptide cathelicidin in the
lesional skin of atopic dermatitis patients in a controlled . . .
Prevalence of atopic dermatitis high among Japanese
adults.(Atopic Dermatitis)
KYOTO, JAPAN -- Atopic dermatitis is one of the most common skin
diseases in Japanese adults, especially those in their 20s and 30s,
according to a first-of-its-kind study.
The high prevalence . . .
Interleukin-17 levels low in skin of atopic lesions.(Atopic
Dermatitis)
KYOTO, JAPAN -- The predisposition to recurrent skin infections in
atopic dermatitis might be explained by the recent discovery that
interleukin-17 is relatively absent in lesional skin, said Dr. . . .
Most antihistamines cause some cognitive impairment.(Atopic
Dermatitis)
KYOTO, JAPAN -- Fexofenadine is the sole truly nonsedating
antihistamine--and the only one that does not cause objectively
measurable cognitive and psychomotor impairment at doses that are
commonly . . .
Atopic patients may not have higher S. aureus risk.(Atopic
Dermatitis)
SAN DIEGO -- Patients with atopic dermatitis are highly colonized
with Staphylococcus aureus but do not appear to be preferentially
infected with community-acquired methicillin-resistant S. . . .
More on the effectiveness of EpiCeram for atopic
dermatitis.(Atopic Dermatitis)
KYOTO, JAPAN -- Topical EpiCeram is an effective stand-alone
therapy for moderate to severe pediatric atopic dermatitis, according to
results of a clinical trial.
This physiologic skin barrier . . .
Barrier products may play role in dermatitis Tx: products can
improve skin hydration and decrease barrier dysfunction, but more
SAN DIEGO -- Barrier products may play a role as adjuvant therapy
for patients with atopic dermatitis, but better studies are needed to
demonstrate their efficacy.
That's the conclusion Dr. . . .
Experience may be dispelling the 'old wives' tales of
botox.
SANTA MONICA, CALIF. -- In the early days of cosmetic botulinum
toxin type A therapy, rumors greatly outnumbered scientific facts about
its safety, storage, and storied effect on furrowed brows and . . .
Angelica: Part II.(Cosmeceutical Critique)
Besides Angelica sinensis, discussed last month, other species of
Angelica have been studied for their medicinal potential, and,
gradually, these species have been introduced into topical . . .
Foundation honors two laser pioneers.(Aesthetic
Dermatology)
The Dermatology Foundation has awarded its prestigious Discovery
Award to Dr. John A. Parrish and Dr. R. Rox Anderson. The award
acknowledges their landmark development of the use of . . .
More women than men seek tattoo removal.(Aesthetic
Dermatology)
More women than men have sought tattoo removal in recent years, a
reversal of the pattern that prevailed 10 years earlier, according to a
report in the Archives of Dermatology.
Today, women . . .
C[O.sub.2] laser offers long-term efficacy.(Aesthethic
Dermatology)(Clinical report)
Facial resurfacing using a C[O.sub.2] laser is a safe and effective
treatment for rhytids demonstrating long-term results, according to a
retrospective study of 47 patients who underwent an entire . . .
Cosmetic devices get mixed marks from panel.(Aesthetic
Dermatology)(Skin Disease Education Foundation seminar)
SANTA MONICA, CALIF. -- Live video demonstrations of several novel
laser and laserlike devices generated mixed reviews from a panel of
dermatologists.
Panelists at a cosmetic dermatology seminar . . .
Gene loss may explain gender differences in melanoma.(Cutaneous
Oncology)
CHICAGO -- A specific pattern of X and Y chromosome losses--and in
particular the loss of an important tumor-suppression gene--was shown in
a recent study to be associated with melanoma . . .
Micro-RNA levels higher in aggressive melanomas.(Cutaneous
Oncology)
CHICAGO -- Micro-RNA-21 and micro-RNA-155 are expressed at
significantly higher levels in primary malignant melanoma tumor samples
than in samples from benign nevi--and in indeterminate . . .
SCC survival doubles with radiotherapy.(Cutaneous
Oncology)
SAN FRANCISCO -- Patients who received adjuvant radiotherapy
following surgery for metastatic cutaneous squamous cell carcinoma
survived more than twice as long as did those who did not . . .
Skin excision not always needed for buccal SCC.(Cutaneous
Oncology)
SAN FRANCISCO -- A 5-year local control rate is possible with or
without skin excision in squamous cell carcinoma of the buccal mucosa,
according to a retrospective study of 331 patients.
When . . .
Renowned educator gets lifetime award.(Cutaneous Oncology)(Brief
article)
The Dermatology Foundation has conferred its Lifetime Career
Educator Award on Dr. Irwin M. Braverman, professor of dermatology at
Yale University School of Medicine. According to the . . .
|
|